Kensey eyes carotids for embolic protection technology
This article was originally published in Clinica
Executive Summary
In its bid to expand the market for its embolic protection technology, Kensey Nash has completed the enrolment phase of a pilot trial for its TriActiv ProGuard system in patients undergoing carotid artery stenting.